That this House has considered Government funding for local pharmacies.
It is an honour to serve under your chairmanship, Mr Betts. I am pleased to have secured this debate, and I thank colleagues from both sides of the House for joining me to discuss this vital pillar of our primary care network.
Community pharmacies are the frontline of healthcare in our constituencies. In Leicester East, they are not just commercial premises but places that serve the very heart of our community. It is estimated that 1.6 million people access pharmacy services in neighbourhoods every day, ranging from elderly residents accessing swift advice to busy families picking up emergency prescriptions and vulnerable constituents using the opportunity to receive healthcare close to home without needing a GP appointment.
Despite that, in Leicester East and across the country this crucial sector is reaching a tipping point. Independent economic analysis of community pharmacy finances for the NHS revealed that community pharmacy is facing a funding gap of around £2.5 billion. As a consequence, England lost roughly 1,000 pharmacies between 2016 and 2026, which is an 8% decline. In Leicester East, we have seen our local provision drop from 32 pharmacies down to 29, which is a net loss of 9% of our local community network.
Behind the numbers is a harsh reality for a vast number of people. We have to consider not only the impact of small business closures on our local high streets, but the everyday consequences for residents who rely on pharmacies for their care. A loss of three pharmacies may sound like a minor shift, but the real implication is deeply concerning. Fewer pharmacies means longer journeys for frail patients, longer queues at the counters that remain open and increased pressure on nearby GP surgeries that are forced to pick up the slack.
We have seen a 19.5% increase in online pharmacies since 2021, and although it is positive that medication and assessments can be accessed in that way, it must be a priority for the Government to protect in-person high street chemists. The closures are obviously not due to a lack of demand. People across my constituency recognise the importance of local pharmacies and use their services constantly. The reason for the closures lies in the structural financial strains that make running an independent pharmacy untenable.
My team and I have had several conversations with the owners and staff of pharmacies across Leicester East, and I recognise and thank them for all their hard work on the frontline of our healthcare provision. They have raised several alarming issues; I hope that, by outlining them today, we can collectively commit to positive and constructive changes to support these independent businesses.
The current reimbursement model for medicines is the first aspect of the system that fails independent providers. As it stands, pharmacies are expected to buy medicines up front. They can then wait anywhere from two to three months for the NHS to reimburse those costs. To make matters more severe, the NHS reimbursement calculation works on the assumption that pharmacies receive massive bulk-buy discounts from suppliers. Large national chains may possess the purchasing power to make that assumption work, but such bulk discounts simply do not exist for a small, independent community pharmacy in Leicester East. Small pharmacies routinely pay more to acquire necessary drugs than the NHS repays them.
Order. Six Members have indicated that they want to speak, so that means they have about seven minutes each. I would normally advise Members to bob if they want to speak in the debate, but two Members have indicated that they have challenging circumstances, so I will exempt them from that requirement on this occasion.
It is a pleasure to serve under your chairship, Mr Betts. As Members might know, I am here today wearing two hats, both pharmacy-shaped, as chair of the all-party parliamentary group on pharmacy and as a community pharmacist for nearly 20 years. The brilliant, unrelenting work of my colleagues in pharmacy teams I saw throughout my career is the reason why this debate is so important. Pharmacists know what it is like to be the first port of call for an unwell patient, to deliver vaccinations to an entire community, and to work exhausting, long days.
I congratulate the hon. Member for Leicester East (Shivani Raja) on securing the debate. My hon. Friend the Member for North Somerset (Sadik Al-Hassan) will be aware that measles outbreaks are increasing, not least because of a decline in measles, mumps and rubella vaccinations. The Government told the Health and Social Care Select Committee, on which I serve, that they need to do more with schools and GPs. We contend that they need to use pharmacies far more. Does my hon. Friend agree with me that as all families visit pharmacies, the Government should enable pharmacies to give MMR vaccinations and grip this properly, so we can crack the challenge of the measles outbreaks, which seem to be increasing in our country?
I thank my hon. Friend for his work on the Select Committee. I agree with him. Pharmacy is well placed to help offer additional vaccination services as well as help with a suite of other minor ailments with an expanded Pharmacy First.
I greatly welcome the uplift for 2026-27 in the pharmacy contract, but let us be honest about the scale of the problem: funding fell by £800 million in real terms between 2015-16 and 2025-26, even as prescription volumes rose by 20%. Last year’s funding settlement was a great amount, but that has been eaten up by a great amount of costs, and the Government’s independent analysis found a £2 billion annual funding gap. Nationally we have lost nearly 1,500 pharmacies since 2017—a 15% contraction of the network. In my own constituency of North Somerset, that story is written in bricks and mortar. We have six fewer pharmacies than in 2016.
Last Friday I visited a community pharmacy in Tiverton, and it was announced on Monday that an application for another pharmacy in my constituency had been turned down. Currently I have three pharmacies in Tiverton when I actually need four. Does the hon. Member agree that we really need to grasp this nettle and make sure we have enough pharmacies on our high streets?
I share the hon. Member’s commitment to getting the right number of pharmacies for the population they serve. That is an important part of not just our high streets, but our communities. We must ensure we have pharmacy services available to people who need them, which reduces the pressure on the rest of the NHS system. The amazing pharmacies still working and dispensing in my constituency dispense over 109,000 prescriptions a month. They deliver thousands of Pharmacy First consultations and have saved as many as 7,370 GP appointments since January 2024.
I recently released my vision of what primary care should look like in 2040 and how we should integrate our system better. It has to be true integration, not just in words but in digital infrastructure. We need a primary care network that knows what happens in different parts of the provision, but also understands how that provision affects the rest of the NHS system. We need a true single patient record that extends beyond general practice and into pharmacy; that will make the funding decisions for the Department easier because we will be able to see the activity even better than we do today.
My message to the Minister is simple: pharmacies are not asking for charity. With some reports suggesting that only 14% of pharmacies are profitable, I am asking for money not to make the job of pharmacy easy, but to make it possible, because it should not be this hard. Pharmacists are asking to be paid properly for work they already do brilliantly. I urge the Government to set out a road map for a six-year funding settlement of £600 million in today’s terms, to invest in the workforce, to allow pharmacies to realise their ambition and finally to close the funding gap, before we lose any more of these vital neighbourhood services.
It is a pleasure to serve under your chairmanship, Mr Betts. It takes me back to the days when as a junior Minister I had to answer to you as chair of the Housing, Communities and Local Government Committee. It is also a great pleasure to follow the hon. Member for North Somerset (Sadik Al-Hassan), who has spoken repeatedly with enormous authority on these matters. He deserves all our thanks for championing pharmacies.
I congratulate my hon. Friend the Member for Leicester East (Shivani Raja) on securing the debate and for her detailed compelling speech. I know she does a terrific job representing her constituents locally because my mum is from Leicester and my family are still there, so I get regular reports. I am here today because my mum was a pharmacist and I spent my childhood working in her pharmacy. I saw at first hand the incredible role that independent community pharmacies play in their local area. With flexible opening hours, their location and no need for an appointment, they can be an easy first port of call for families when they need help, care and advice.
I am struck that community pharmacists always want to go above and beyond for their patients. One of my first jobs for my mum was to ride around on my bike in the evenings delivering prescriptions to elderly patients who could not make it in or needed them urgently. That was a sign for me of the role that pharmacists play in their local areas. That is why, extraordinarily, about 80% of those over the age of 65 have visited their local pharmacy over the past three months, which speaks to the role they play.
I agree that we need expanded services for our pharmacies, but does the right hon. Member agree that should come with adequate remuneration? At the moment, pharmacists are saying they are doing a lot more for a lot less.
Of course. I am sure when the Minister looks at what services can be expanded, she will make sure they are funded properly and will look at where they will relieve strain elsewhere in the healthcare system. If we look at system costs, pharmacies can help save money. Some of the other conditions covered in Scotland include eye issues such as conjunctivitis, dermatological conditions such as acne, and chest infections.
Finally, the hon. Member for North Somerset touched on joined-up care. If we want a truly joined-up primary care service, we need single patient records. Examining whether pharmacies can be integrated into GP Connect is worth exploring.
I thank the Minister for being a champion for pharmacies inside the Government. Obviously, the issue is personal for me, but there is widespread support for pharmacies among colleagues and society. They deserve our gratitude and support, and I urge the Government to continue to back them.
It is a pleasure to serve under your chairship, Mr Betts. I thank the hon. Member for Leicester East (Shivani Raja) for securing this important debate. I declare an interest as a vice-chair of the APPG on pharmacy, my colleague on which, the hon. Member for North Somerset (Sadik Al-Hassan), I am happy to follow.
For many residents in rural constituencies such as mine, local pharmacies are the first, and often only, point of contact with the NHS. Longer distances to travel, limited public transport and patchy digital connectivity mean that the trusted and timely in-person service that they provide for our communities is vital. However, access is thin on the ground.
Analysis by the National Pharmacy Association has described west Berkshire as England’s “pharmacy desert”, with the lowest number of pharmacies per head of any council area. To put that in context, the UK average is about one pharmacy to every 4,600 patients; in my constituency, it is one to every 7,200. Twelve pharmacies still open their doors to residents across Newbury and west Berkshire, and they do essential, extraordinary work. They dispense more than 111,000 prescriptions every month and deliver enough consultations through Pharmacy First to save more than 8,000 GP appointments, all while acting as a specialist and friendly front door to our NHS.
3:02 pm
20 of 56 shown
Although concessionary pricing mechanisms exist to adjust for market spikes, the delay in the adjustments means that independent contractors are constantly left bridging the shortfall. That disparity forces wholesalers to look overseas for cheaper stock, creating supply chain bottlenecks and leaving local pharmacists to face the frustration of patients when vital medicines are backordered for weeks.
The Independent Pharmacies Association recently conducted research that shows that an average pharmacy dispensing 10,000 items a month still faces a shortfall of circa £56,000 compared with what is needed to keep in pace with inflation. Pharmacies cannot be expected to continue to foot this bill. The Government must do more to ensure that pharmacies are properly reimbursed, to prevent further pressure and demand on other areas of our NHS.
On top of the margin pressures, pharmacy owners in my constituency are caught in a constant struggle between rising operating costs and completely fixed incomes. Over recent years, overheads have increased right across the board. The recent decisions to raise employer national insurance contributions and the minimum wage and to escalate business rate liabilities have significantly increased the financial burden on pharmacies up and down the country. Furthermore, unlike other small high street businesses, community pharmacies receive no business rates reliefs on their premises—a major oversight for essential healthcare providers operating right at the heart of our local economies.
When running costs go up for a normal high street business, such as a local shop, café or dry cleaners, it can adjust its prices to cover higher wage bills and energy costs. Independent communities pharmacies cannot do that. Their primary income is fixed directly by the Government tariff. When employment taxes increase or utility bills rise, independent business owners cannot pass those costs on. They must absorb the loss directly until their reserves run dry.
I welcome that our new Prime Minister has introduced business rates relief for the leisure and hospitality sector, but does the Minister agree that we must also introduce further assistance for the pharmacy sector? GP and dental premises benefit from the NHS reimbursement of business rates, while community pharmacies, which also provide vital frontline services, do not. Introducing a form of relief to end the disparity for local pharmacies would make a substantial difference.
In addition to the fixed margins, the current funding framework expects community pharmacies to deliver essential services at a financial loss. For example, home delivery services for housebound or vulnerable residents became vital during the pandemic, and remain a crucial lifeline for many elderly constituents across Leicester East, but local pharmacies receive no core NHS funding to run delivery vehicles or pay driver wages. They fund the operations entirely by themselves, committing their own profit to ensure that vulnerable patients receive their medication on time.
In addition, pharmacy owners have described how, although the Government support preventive clinical services, the rules and restrictions imposed are unnecessarily constraining. It is positive that vaccinations and immunisation are being moved into pharmacies, but the Independent Pharmacies Association suggests that shifting more flu vaccinations into pharmacies could free up around 4.5 million GP appointments each year. As we approach winter and flu season, the Government should seriously consider the benefits of reallocating services, and ensure that proper funding is in place to back up the increased expectations.
Blood pressure screening is another service that is being redirected to pharmacies. It is a simple, cost-effective way to catch cardiovascular issues early and prevent avoidable hospital admissions, yet under the current NHS caps reimbursement is limited to just one check per patient every five years.
No small business can survive indefinitely when its costs are rising, its prices are frozen by the Government and it is expected to deliver services for free. This financial pressure feeds directly into an acute workforce crisis. The pharmacy pressures survey published by Community Pharmacy England revealed stark results: 60% of pharmacy teams reported active staffing shortages, and 54% of owners said they were struggling to recruit permanent staff. Crucially, more than 80% reported longer patient wait times and more than half acknowledged that shortages were reducing their ability to offer direct advice.
We are also seeing a troubling rise in temporary closures, when a pharmacy must shut its doors for hours or days at a time simply because it cannot secure a qualified pharmacist. The freedom of information data collected by Healthwatch across various integrated care boards revealed that, in a single year, there were nearly 14,000 temporary closures across England, resulting in over 46,000 lost hours of care.
Without strategic planning for staffing, the long-term future of our community pharmacies remains deeply uncertain. The Company Chemists’ Association estimates that England could face a shortfall of 16,000 community pharmacists by 2036. While it is positive that thousands of pharmacists have been recruited into the GP practices via the additional roles reimbursement scheme, we must be careful not to strip our high street pharmacies of the very talent they need to remain open.
As the long-awaited NHS long-term workforce plan continues to undergo revisions, it is vital that the Government give sufficient priority to the baseline staffing needs of community pharmacy. We know that expanded training targets and the roll-out of independent prescribing qualification upon registration present a real opportunity to expand clinical care on our high streets. Similarly, recent regulatory challenges to allow pharmacy technicians to supply specified medicines and deliver services under the Pharmacy First scheme have the potential to free up valuable pharmacist time. But none of these reforms will succeed if the underlying pharmacy network is allowed to shrink due to unfunded operational mandates.
I want to be entirely fair to the Government and to Ministers and acknowledge that we have seen some positive movement in this policy area. Progress is being made, but we must ensure that the pace of our action matches the urgency of the situation before us. The community pharmacy contractual framework—CPCF—settlement for 2026-27 secured almost £3.7 billion for the sector, which is a £340 million increase on the previous year. That builds on the two-year agreement that saw funding rise in previous settlements. Pharmacy trade bodies have expressed concern, however, that the funding uplift will not be sufficient to support the introduction of independent prescribing. We must ensure that the new expectations placed on pharmacies to share services are matched by funding commitments.
We have also seen practical relief in the write-off of historic pandemic-era medicine margin debt, and in adjustments to the single activity fee. Furthermore, the roll-out of the Pharmacy First scheme has demonstrated the real appetite for community-level care. Across England, more than 10,900 pharmacies are participating, delivering millions of consultations for common conditions like earache, shingles and minor infections. That is a demonstration of real and effective triage that takes pressure off A&E departments and GP surgeries.
However, we must listen to what sector stakeholders are telling us. Community Pharmacy England welcomed the recent funding adjustments as a step away from real-term cuts, but was explicit that this was a “first step” towards stability and not the final destination. The National Pharmacy Association made the same point: structural underfunding means that current settlements will struggle to match the “true cost” of service delivery. The Health and Social Care Committee was blunt in its analysis, describing the current CPCF funding model as “not fit for purpose” and “overly complex”.
A major flaw in the scheme is that pharmacies only get paid for many clinical services if local GPs or hospitals actively refer patients to them. In practice, that leaves independent business owners completely dependent on someone else’s admin system, meaning many pharmacies are fully staffed and ready to treat people but receive zero referrals simply because a local surgery is not using the system properly.
The current policy framework is simply not delivering for our high streets, and we need an operational model fit for the next decade. If we want pharmacies to continue delivering on the frontline, expanding Pharmacy First, delivering preventive health checks and taking pressure off our local GP surgeries, we must fix the underlying economic model that keeps their doors open.
As a Conservative, I believe in supporting small business owners, encouraging enterprise and removing unnecessary administrative barriers. High street pharmacies are independent businesses delivering frontline public care efficiently, but when Government policy sets fixed tariffs while escalating business rates liabilities and employment taxes, it creates a system that actively undermines independent providers.
I ask the Minister to address four specific, practical areas today. The first is reimbursement reform. We must review the drug reimbursement formula and concessionary pricing mechanisms, so that payment calculations reflect the actual market acquisition prices paid by the independent pharmacies, rather than relying on assumed bulk discount rates that small independent businesses simply cannot access.
The second area is contractual and operational certainty. We need to update the CPCF to ensure that core funding is predictable, transparent and fair, rather than heavily dependent on variable, patchy referral targets managed by NHS bodies over which pharmacy owners have no control.
The third area is business overhead and rates relief. I urge the Minister to work with colleagues in the Treasury to address the cumulative tax and cost burden facing small health providers. That includes reviewing business rates liabilities and the impact of the employer national insurance contribution increases on independent high street providers.
The final area is workforce and capacity support. NHS workforce planning must balance the expansion of primary care roles with the baseline staffing requirements of high street community pharmacies. As policies such as independent prescribing expand, Ministers must ensure that independent pharmacies are provided with the direct resource and funding needed to put clinical roles into practice safely.
Community pharmacies are one of the most cost-effective, high-impact assets that our healthcare system possesses. They keep people well, they prevent avoidable emergency admissions, and they give local high streets across Leicester East and the country vital commercial and civic life. The current approach needs real correction to ensure that independent business owners and patients are properly supported. I look forward to hearing the Minister’s response, and I urge the Government to give our local pharmacies the financial certainty and stability that they desperately need and deserve.
I see that in my constituency. We have great national pharmacies as well as brilliant independent ones, such as Coopers in Great Ayton, the Village Pharmacy in Catterick, Stokesley pharmacy and Central Dales pharmacy in Hawes, providing vital healthcare in a sparsely populated rural area and reinforcing the lifeline that pharmacies provide. A benefit of knowing pharmacists for the majority of my life is that I have seen the transformation in the role they play. Originally, they just dispensed prescriptions for GPs. My dad was a GP, so I also saw that side of it. They have transformed to being the first port of call for primary healthcare and treatment for minor illnesses.
That evolution had various moments, which the hon. Member for North Somerset will also have experienced. Starting in about 2000, the introduction of hypertension and blood pressure services made a difference. Medicine use reviews were a big statement of trust in what pharmacists could do. The ability to dispense urgent repeat prescriptions made a huge difference to patients. More recently, there has been the introduction of oral contraception and smoking cessation services, as well as flu jabs, catalysed by covid and now accounting for about 30% of those dispensed, which is a huge increase.
That evolution over the past 25 years demonstrates the faith that successive Governments of all stripes have had in pharmacies. Patients and local communities place faith in their pharmacists because they trust them and value what they do; they know that they can provide healthcare in an accessible way. That is why, when in government, we introduced Pharmacy First, of which I am very proud. Pharmacists were enabled to provide medication for seven common conditions, including sinusitis, sore throats, ear infections and urinary tract infections. Obviously, that got off to a slower start than we would have liked, but it now has almost 100% take-up among pharmacies. When I last checked the stats, something like 7 million consultations had taken place and more than 5 million prescriptions had been supplied. High satisfaction in the service is growing by 30% to 40% year over year. It has continued the evolution of increasing trust in pharmacies and providing care closer to people in their communities.
I have three questions for the Minister about how to continue that journey and re-emphasise support for pharmacies. The first is about raising awareness and trust. In the last debate on pharmacies here, which I think the hon. Member for North Somerset secured, the Minister gave some stats about the high awareness of the Pharmacy First scheme. Anecdotally, that did not quite jibe with my personal experience. Is there something we can do collectively to raise awareness of Pharmacy First and, as was touched on, make sure that the healthcare system is on the same page, so that people get the same message from 111, their GP or the hospital about what is available at the pharmacy, and so they can trust their pharmacist to deliver that service?
Secondly, we should look at expanding Pharmacy First, which, in a welcome fashion, the Government have indicated they are minded to do. There are a couple of options for that: we could consider whether the existing restrictions for the seven services, which are limited in part by gender or age, can be expanded. We could also look across the border to Scotland to see what other conditions the service could be expanded to.
Like many here, I welcome the Government’s recent investment in the sector. We have heard the cash figures, but the 10.3% uplift for 2026-27 is the largest increase anywhere in primary care this year, and the move to expand prescribing rights is a vital step in the right direction. However, a positive uplift does not in isolation deliver the sustainable settlements that pharmacies desperately need. Pharmacies cannot plan their workforce or their services throughout the year when settlements are negotiated and have to be fought for year by year. Nationally, we have lost over 1,300 pharmacies since 2016, and this year’s uplift will not plug the underlying funding gap, which now stands at over £2 billion. It is no wonder that Community Pharmacy England accepted this year’s deal on the condition of further reform, stating clearly:
“Accepting this deal does not mean we think it is enough”.
With budgets stretched, that instability is compounded by broken medicine supply chains and a framework that leaves many pharmacies in the impossible position of dispensing medicines at a loss. On visits to Lambourn pharmacy and MedWell chemist in Newbury, staff told me that current funding would quickly be absorbed by rocketing drug prices, with some pharmacies paying 14 to 15 times more for prescription medicine than at the start of the year. In rural areas, where proximity to provision is already paramount, older residents in particular cannot afford to lose access to their prescription because their pharmacy down the road has been priced out of existence. Despite those challenges, pharmacies are doing incredible work, and I know how much residents across Newbury and West Berkshire value their expertise and care.
In September 2024, the Government commissioned the Lord Darzi report, which rightly acknowledged the huge potential of pharmacies within the NHS. Two years on, with a workforce eager to do all it can, that potential remains unfulfilled—not for a lack of experience and care, but because of a lack of investment from the centre. The 10-year health plan’s ambition to shift care from hospitals into communities is absolutely the right one, and pharmacies are the linchpin of that push. As their responsibilities continue to rise, so must the Government’s backing. Pharmacies have spent the last 10 years being squeezed to near breaking point; the next 10 and beyond must be different.
I therefore ask the Minister to launch a strategic review of medicine supply, including reforms needed to build domestic manufacturing capability, and to commit to an above-inflation multi-year funding settlement that allows pharmacies to continue to serve my constituents and millions of patients across the country for decades to come.